Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 753 clinical trials
Camrelizumab Combined With Radiotherapy for Adjuvant Treatment of Esophageal Squamous Cell Carcinoma After Surgery

This is an investigator-initiated, single-arm, single-center, exploratory clinical study.The study population consisted of patients with R0 resection of esophageal squamous cell carcinoma who

  • 0 views
  • 13 Feb, 2021
  • 1 location
Survival Benefit of Elective Neck Dissection in T1 2N0M0 Oral Squamous Cell Carcinoma

Controversy over surgical treatment of clinically negative neck in early stage oral squamous cell carcinoma revolves around the uncertainty of its impact on patient prognosis. The efficacy of

  • 4 views
  • 21 Jan, 2021
  • 2 locations
Circulating Tumor Cells as an Early Predictive head-and -Neck Squamous-cell Carcinoma

In France, the incidence of head and neck squamous cell carcinomas (HNSCC) is 16 000 new cases/year. During these last years, many new chemotherapies and targeted therapies have been developed

  • 1 views
  • 08 Nov, 2020
Low Level Laser Therapy for Radiation Induced Dermatitis in H & N Squamous Cell Carcinoma

for head and neck squamous cell carcinoma (HNSCC). Additional objectives include assessment of patient-reported quality of life data, pain parameters and dermatologic quality of life responses. The

  • 2 views
  • 24 Jan, 2021
  • 1 location
Cabozantinib in Patients With Advanced Penile Squamous Cell Carcinoma (PSCC) (CaboPen)

Cabozantinib in patients with advanced penile squamous cell carcinoma (PSCC): an open-label, single-center, phase 2, single-arm trial (CaboPen)

  • 0 views
  • 03 Mar, 2021
  • 1 location
Cetuximab & Concomitant-Boost Accelerated RT in Patients With Locally Advanced Oropharynx Squamous Cell Carcinoma.

The purpose of this study is to determine the 1-year rate of locoregional disease control in the experimental arm, using a control arm to avoid selection bias.

  • 15 views
  • 07 Nov, 2020
  • 1 location
A Phase III Study of Nimotuzumab Plus Concurrent Chemoradiotherapy in Loco-regional Esophageal Squamous Cell Carcinoma

suggested synergy between nimotuzumab, paclitaxel, cisplatin and radiation. For our phase II study in locally advanced esophageal squamous cell carcinoma (ESCC), the combination of cetuximab and

  • 0 views
  • 21 Jan, 2021
  • 12 locations
Trial of Docetaxel Cisplatin Fluorouracil (5-FU) for Unresectable Advanced Esophageal Squamous Cell Carcinoma (ESCC)

This phase I/II study is being conducted to determine the maximum-tolerated dose (MTD), dose-limiting toxicity (DLT), and efficacy of a combination chemotherapy using docetaxel, cisplatin and 5-fluorouracil (DCF) in unresectable advanced esophageal cancer. The usefulness of the this regimen is evaluated by RECIST, time to progression and median survival time.

ct scan
combination chemotherapy
platelet count
measurable disease
recurrent esophageal cancer
  • 9 views
  • 07 Nov, 2020
  • 1 location
Sintilimab Injection Combined With Concurrent CCRT in Locally Advanced Esophageal Squamous Cell Carcinoma

This study evaluated the effectiveness and safety of sintilimab combined with cCRT in patients with locally advanced ESCC.

  • 0 views
  • 25 Jan, 2021
  • 1 location
Study of IBI318 in Patients With Advanced Cutaneous Squamous Cell Carcinoma

The purpose of this study is to evaluate the safety and efficacy of IBI318 (anti-PD-1/PD-L1) in adult participants with metastatic (nodal or distant) cutaneous squamous cell carcinoma (CSCC), or

  • 0 views
  • 27 Jan, 2021
  • 1 location